A prospective cross-sectional survey comparing patient and provider expectations regarding ovarian cancer prognosis

por Huepenbecker, Sarah P., Zhang, Xiaochen, Morgan, Mark A., Haggerty, Ashley F.
Publicado 2022

The TrueBlue model of collaborative care using practice nurses as case managers for depression alongside diabetes or heart disease: a randomised trial

por Morgan, Mark A J, Coates, Michael J, Dunbar, James A, Reddy, Prasuna, Schlicht, Kate, Fuller, Jeff
Publicado 2013

Isolated distant lymph node metastases in ovarian cancer. Should a new substage be created?

por Nasioudis, Dimitrios, Ko, Emily M., Haggerty, Ashley F., Giuntoli, Robert L., Burger, Robert A., Morgan, Mark A., Latif, Nawar A.
Publicado 2019

Role of adjuvant chemotherapy in the management of stage IC ovarian granulosa cell tumors

por Nasioudis, Dimitrios, Ko, Emily M., Haggerty, Ashley F., Giuntoli, Robert L., Burger, Robert A., Morgan, Mark A., Latif, Nawar A.
Publicado 2019

Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target

por Pierini, Stefano, Tanyi, Janos L., Simpkins, Fiona, George, Erin, Uribe-Herranz, Mireia, Drapkin, Ronny, Burger, Robert, Morgan, Mark A., Facciabene, Andrea
Publicado 2020

Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcoma

por Cory, Lori, Brensinger, Colleen, Burger, Robert A., Giuntoli, Robert L., Morgan, Mark A., Latif, Nawar, Lin, Lilie L., Ko, Emily M.
Publicado 2022

Disparities in cancer-specific and overall survival in black women with endometrial cancer: A Medicare-SEER study

por Saris, Daniel H., Smith, Anna Jo Bodurtha, Brensinger, Colleen, Kim, Sarah H., Haggerty, Ashley F., Latif, Nawar, Cory, Lori, Giuntoli, Robert L., Morgan, Mark A., Lin, Lilie L., Ko, Emily M.
Publicado 2022

H2Bub1 loss is an early contributor to clear cell ovarian cancer progression

por Ferrari, Adam J., Rawat, Priyanka, Rendulich, Hannah S., Annapragada, Akshaya V., Kinose, Yasuto, Zhang, Xiaoming, Devins, Kyle, Budina, Anna, Scharpf, Robert B., Mitchell, Marilyn A., Tanyi, Janos L., Morgan, Mark A., Schwartz, Lauren E., Soong, T. Rinda, Velculescu, Victor E., Drapkin, Ronny
Publicado 2023

A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)

por Monk, Bradley J., Parkinson, Christine, Lim, Myong Cheol, O'Malley, David M., Oaknin, Ana, Wilson, Michelle K., Coleman, Robert L., Lorusso, Domenica, Bessette, Paul, Ghamande, Sharad, Christopoulou, Athina, Provencher, Diane, Prendergast, Emily, Demirkiran, Fuat, Mikheeva, Olga, Yeku, Oladapo, Chudecka-Glaz, Anita, Schenker, Michael, Littell, Ramey D., Safra, Tamar, Chou, Hung-Hsueh, Morgan, Mark A., Drochýtek, Vít, Barlin, Joyce N., Van Gorp, Toon, Ueland, Fred, Lindahl, Gabriel, Anderson, Charles, Collins, Dearbhaile C., Moore, Kathleen, Marme, Frederik, Westin, Shannon N., McNeish, Iain A., Shih, Danny, Lin, Kevin K., Goble, Sandra, Hume, Stephanie, Fujiwara, Keiichi, Kristeleit, Rebecca S.
Publicado 2022